Interview and article by Christine Clark. The anti-tumour effects of ivermectin have been described in the literature and the liposomal delivery system developed by Mountain Valley MD could be the key to making this work in practice, according to Dennis Hancock, President and CEO of Mountain Valley MD. [embedded content] The anti-tumour effects of ivermectin have been reported in the […]
Interview and article by Christine Clark. Liposomal drug delivery holds out the prospect of oral drug administration without the need for water and vaccine more economical use of oral vaccines, according to Dennis Hancock, President and CEO of Mountain Valley MD. [embedded content] IvectosolTM, the solubilised form of ivermectin produced by Mountain Valley MD has been tested against three variants […]
Interview and article by Christine Clark. Patented solubilisation technology improves the bioavailability of oral ivermectin and makes possible the formulation of an ivermectin injection for human use, according to recent work undertaken by Mountain Valley MD in Canada. IMI spoke to Dennis Hancock, President and CEO of Mountain Valley MD to find out more. [embedded content] Mountain Valley MD is […]
Recent Comments